In this issue of European Respiratory Journal , Viglino et al. [1] report that nonalcoholic fatty liver disease (NAFLD) is highly prevalent in chronic obstructive pulmonary disease (COPD) and might contribute to cardiometabolic comorbidities. Pneumologists should be aware of possible liver comorbidities, including NAFLD, in their COPD patients